Suicidality is a significant public health problem that results in morbidity, loss of individual life, potential grief to loved ones, and significant healthcare expenditure.
The Thompson Institute is conducting world-leading research to prevent suicide. This includes clinical trials of novel treatments for suicidality, and research addressing four components of suicide prevention:
- Promoting health and wellbeing
- Supporting people who are upset
- Mental health assessment
- Evidence-based interventions
Outcomes
What our research has discovered
Clinical Trial - Novel treatment of suicidality
Suicide prevention research. Clinical trial - OKTOS at the Thompson Institute.
Other research projects
- Evaluation of a new approach to supporting people who have suicidal thoughts (led by Gabe Hart)
- Improving mental healthcare assessment (led by Professor Helen Stallman)
- Effect of unhealthy coping on cognition in young adolescents (Led by Ruby Billings)
- Understanding barriers to help-seeking for mental health problems (led by Tim Kelly)
- Measurement of suicidality (led by Kim Woods)
- The trajectory of suicidality in early adolescence (led by Kylie Van Doren)
- Wellbeing of Paramedics (led by Professor Helen Stallman)
- Effect of developmental competencies on health behaviours (led by Rebekah Van Der Kooy)
- Developmental Interpersonal Trauma Disorder (led by Professor Helen Stallman)
- Psychometric Properties of the Parenting Efficacy Index (led by Richard Bojack)
- Developmental competencies and Parenting Efficacy
- Effectiveness of Creative Writing to Improve Developmental Competencies
- Evaluation of Coping Kids to prevent mental illness and suicide
Research contacts
Clinical trials: Megan Dutton
Partnerships: Mervat Quirke